These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
484 related items for PubMed ID: 29178898
1. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections. Castro L, Pecha S, Linder M, Vogler J, Gosau N, Meyer C, Willems S, Reichenspurner H, Hakmi S. J Cardiothorac Surg; 2017 Nov 25; 12(1):99. PubMed ID: 29178898 [Abstract] [Full Text] [Related]
2. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry. Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ. JACC Clin Electrophysiol; 2017 Mar 25; 3(3):243-250. PubMed ID: 29759518 [Abstract] [Full Text] [Related]
3. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator. Tanawuttiwat T, Garisto JD, Salow A, Glad JM, Szymkiewicz S, Saltzman HE, Kutalek SP, Carrillo RG. Pacing Clin Electrophysiol; 2014 May 25; 37(5):562-8. PubMed ID: 24762055 [Abstract] [Full Text] [Related]
7. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting. Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M. BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442 [Abstract] [Full Text] [Related]
8. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients. Erath JW, Vamos M, Sirat AS, Hohnloser SH. Clin Res Cardiol; 2017 Apr 15; 106(4):300-306. PubMed ID: 27888304 [Abstract] [Full Text] [Related]
9. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ. J Am Coll Cardiol; 2013 Nov 19; 62(21):2000-2007. PubMed ID: 23916930 [Abstract] [Full Text] [Related]
10. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator. Martens P, Verbrugge FH, Nijst P, Dupont M, Nuyens D, Herendael HV, Rivero-Ayerza M, Tang WH, Mullens W. Heart; 2017 Dec 19; 103(24):1977-1984. PubMed ID: 28716973 [Abstract] [Full Text] [Related]
11. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator. Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V. Heart Rhythm; 2021 Mar 19; 18(3):404-410. PubMed ID: 33248269 [Abstract] [Full Text] [Related]
12. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A, Zareba W, Moss AJ. Pacing Clin Electrophysiol; 2010 Mar 19; 33(3):353-67. PubMed ID: 19889186 [Abstract] [Full Text] [Related]
13. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU, Goldenberg I, Moss AJ. Eur Heart J; 2013 Aug 19; 34(29):2230-42. PubMed ID: 23729691 [Abstract] [Full Text] [Related]
14. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience. Sasaki S, Shoji Y, Ishida Y, Kinjo T, Tsushima Y, Seno M, Nishizaki F, Itoh T, Izumiyama K, Yokota T, Yokoyama H, Yamada M, Horiuchi D, Kimura M, Higuma T, Tomita H, Okumura K. J Cardiol; 2017 Jan 19; 69(1):359-363. PubMed ID: 27595899 [Abstract] [Full Text] [Related]
15. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis. Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK. J Heart Lung Transplant; 2015 Oct 19; 34(10):1305-9. PubMed ID: 26094085 [Abstract] [Full Text] [Related]
16. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report. Andresen H, Sasko B, Patschan D, Pagonas N, Ritter O. J Med Case Rep; 2021 May 17; 15(1):243. PubMed ID: 33993888 [Abstract] [Full Text] [Related]
17. Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Sasaki S, Tomita H, Shibutani S, Izumiyama K, Higuma T, Itoh T, Sasaki K, Horiuchi D, Kimura M, Okumura K. Circ J; 2014 May 17; 78(12):2987-9. PubMed ID: 25366562 [Abstract] [Full Text] [Related]
18. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection. Unsworth JD, Zaidi A, Hargreaves MR. Europace; 2015 Nov 17; 17(11):1708-11. PubMed ID: 25883081 [Abstract] [Full Text] [Related]
19. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I. Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618 [Abstract] [Full Text] [Related]
20. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study. Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C. J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]